Sean Nolan - Chief Executive Officer @ Taysha Gene Therapies

Start Free Trial

Pricing

Overview

Number of Portfolio Companies

Number of Current Board & Advisor Roles

Primary Job Title Chief Executive Officer
Primary Organization
Taysha Gene Therapies

Location Chicago, Illinois, United States
Regions Greater Chicago Area, Great Lakes, Midwestern US
Gender Male

Investor Type
obfuscated
obfuscation

LinkedIn View on LinkedIn

Sean P. Nolan is based out of Chicago, Illinois, and is the Chief Executive Officer and Chairman of the Board of Directors at Taysha Gene Therapies. Sean previously served as the President and Chief Executive Officer at AveXis Inc

Personal Investments

Number of Investments

Sean Nolan

invested in

Jaguar Gene Therapy

obfuscation

. This investment -

Series B - Jaguar Gene Therapy

- was valued at

obfuscation

Announced Date	Organization Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Jaguar Gene Therapy	—	Series B - Jaguar Gene Therapy	obfuscated obfuscation

Partner Investments

Number of Partner Investments

Announced Date	Organization Name	Investor Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Taysha Gene Therapies	Nolan Capital	—	Series B - Taysha Gene Therapies	obfuscated obfuscation
obfuscated obfuscation	Taysha Gene Therapies	Nolan Capital	Yes	Seed Round - Taysha Gene Therapies	obfuscated obfuscation

Jobs

Number of Current Jobs

Number of Past Jobs

Sean Nolan

is the

Chief Executive Officer

Taysha Gene Therapies

. Additionally,

Sean Nolan

has had

past jobs including

President and Chief Executive Officer

AveXis

Taysha Gene Therapies Chief Executive OfficerDec 16, 2022

Organization Name	Title At Company	Start Date	End Date
AveXis	President and Chief Executive Officer	Jun 2015	May 2018
InterMune	Executive Vice President and Chief Business Officer	Feb 2013	Jun 2015

Board and Advisor Roles

Number of Current Board & Advisor Roles

Sean Nolan

is the

Chairman of the Board of Directors

Taysha Gene Therapies

Taysha Gene Therapies Chairman of the Board of DirectorsMar 2020

Related Hubs

Hub Name	CB Rank (Hub)
Invus Portfolio Companies	56,806
United States Public Companies With Less Than $50M in Revenue	12,377
Life Science Companies that Exited	12,288
Silicon Valley Bank Portfolio Companies	24,140
Life Science Companies With Fewer Than 1000 Employees	6,415
Life Science Companies With Less Than $1B in Revenue	10,985
United States Genetics Companies	17,180
United States Biotechnology Public Companies	13,467
Biotechnology Public Companies With Less Than $1B in Revenue	10,026
Life Science Companies (Top 10K)	3,202